abstract |
the present invention relates to a pharmaceutical formulation of (s) - [2-chloro-4-fluoro-5- (7-morpholin-4-ylquinazolin-4-yl) -phenyl] - (6-methoxy-pyridazin- 3-il) ¬methanol or its pharmaceutically acceptable salt, as well as a method of production of the same, as well as its medical uses. |